Chromaway AB – Trademark Portfolio
Entity Type: 99
Chromaway AB holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include CHROMA, ESPLIX, CHROMIA, CHROMAWAY, and POSTCHAIN.
No18 Centralplan 15
SE-111 20 Stockholm
Showing of trademarks Trademarks
Trademark Classifications
Chromaway AB's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Chromaway AB have?
Chromaway AB has 9 U.S. trademarks filed with the USPTO. Of these, 9 registered.
What trademark classes does Chromaway AB file in?
Chromaway AB files trademarks across 4 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Chromaway AB's most well-known trademarks?
Chromaway AB's registered trademark portfolio includes well-known marks such as CHROMA, ESPLIX, CHROMIA, CHROMAWAY, and POSTCHAIN. These are among 9 currently registered trademarks in the portfolio.
What is Chromaway AB's trademark registration success rate?
Chromaway AB has a 100% trademark registration rate, with 9 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.